相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polymorphic Transporters and Platinum Pharmacodynamics
Jason A. Sprowl et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Association of ERCC1-C118T and-C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: A pooled analysis based on 39 reports
Tong-Peng Xu et al.
GENE (2013)
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer
Francesca Mazzoni et al.
LUNG CANCER (2013)
Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapy
Helen Vassalou et al.
LUNG CANCER (2013)
Predictive Value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPO-IIA, TOPOIIB and C-MYC Genes in Patients with Small Cell Lung Cancer (SCLC) Who Received First Line Therapy with Cisplatin and Etoposide
Niki Karachaliou et al.
PLOS ONE (2013)
Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations
H. E. Wheeler et al.
PHARMACOGENOMICS JOURNAL (2013)
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
C. Fernandez-Rozadilla et al.
PHARMACOGENOMICS JOURNAL (2013)
NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones
David Siegel et al.
BIOCHEMICAL PHARMACOLOGY (2012)
CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel
Daniel L. Hertz et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study
Daniela Caronia et al.
PLOS ONE (2011)
Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study
Hee Seung Kim et al.
GYNECOLOGIC ONCOLOGY (2009)
Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
D. Caronia et al.
PHARMACOGENOMICS JOURNAL (2009)
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: The Scottish randomised trial in ovarian cancer
Sharon Marsh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The IASLC lung cancer staging project: Validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Patti A. Groome et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
A silent polymorphism in the MDR1 gene changes substrate specificity
Chava Kimchi-Sarfaty et al.
SCIENCE (2007)
Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy
S. Sakano et al.
BRITISH JOURNAL OF CANCER (2006)
Multiplex pyrosequencing of two polymorphisms in DNA repair gene XRCC1
Tahar van der Straaten et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer
Xifeng Wu et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
mdr-1 single nucleotide polymorphisms in ovarian cancer tissue:: G2677T/A correlates with response to paclitaxel chemotherapy
H Gréen et al.
CLINICAL CANCER RESEARCH (2006)
Association between glutathione S-transferase π polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma
C Lu et al.
CANCER (2006)
Single nucleotide polymorphisms modify the transporter activity of ABCG2
K Morisaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Glutathione S-transferase polymorphisms and survival in primary malignant glioma
MF Okcu et al.
CLINICAL CANCER RESEARCH (2004)
Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer - A meta-analysis
C Delbaldo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes
N Bahadur et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Non-synonymous single nucleotide alterations found in the CYP2C8 gene result in reduced in vitro paclitaxel metabolism
A Soyama et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2001)
Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
U Peters et al.
ANTI-CANCER DRUGS (2000)
分享论文
